Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016 (2016), Article ID 5832051, 7 pages
http://dx.doi.org/10.1155/2016/5832051
Research Article

Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis

1Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 403-720, Republic of Korea
2Department of Hospital Pathology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 403-720, Republic of Korea

Received 7 September 2015; Accepted 2 November 2015

Academic Editor: Paolo Gionchetti

Copyright © 2016 Dae Bum Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Laharie, J. Filippi, X. Roblin et al., “Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience,” Alimentary Pharmacology and Therapeutics, vol. 37, no. 10, pp. 998–1004, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kobayashi, M. Naganuma, S. Okamoto et al., “Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis,” Journal of Gastroenterology, vol. 45, no. 11, pp. 1129–1137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rutter, B. Saunders, K. Wilkinson et al., “Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis,” Gastroenterology, vol. 126, no. 2, pp. 451–459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Mazzuoli, F. W. Guglielmi, E. Antonelli, M. Salemme, G. Bassotti, and V. Villanacci, “Definition and evaluation of mucosal healing in clinical practice,” Digestive and Liver Disease, vol. 45, no. 12, pp. 969–977, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. B. I. Korelitz and S. C. Sommers, “Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes,” The American Journal of Gastroenterology, vol. 64, no. 5, pp. 365–370, 1975. View at Google Scholar · View at Scopus
  6. C.-H. Florén, C. Benoni, and R. Willén, “Histologic and colonoscopic assessment of disease extension in ulcerative colitis,” Scandinavian Journal of Gastroenterology, vol. 22, no. 4, pp. 459–462, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. R. B. Gupta, N. Harpaz, S. Itzkowitz et al., “Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study,” Gastroenterology, vol. 133, no. 4, pp. 1099–1105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. P. L. Travis, P. D. R. Higgins, T. Orchard et al., “Review article: defining remission in ulcerative colitis,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 2, pp. 113–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Peyrin-Biroulet, A. Bressenot, and W. Kampman, “Histologic remission: the ultimate therapeutic goal in ulcerative colitis?” Clinical Gastroenterology and Hepatology, vol. 12, no. 6, pp. 929.e2–934.e2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Geboes, R. Riddell, A. Öst, B. Jensfelt, T. Persson, and R. Löfberg, “A reproducible grading scale for histological assessment of inflammation in ulcerative colitis,” Gut, vol. 47, no. 3, pp. 404–409, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. C. H. Choi, S. A. Jung, B. I. Lee, K. M. Lee, J. S. Kim, and D. S. Han, “Diagnostic guideline of ulcerative colitis,” The Korean Journal of Gastroenterology, vol. 53, no. 3, pp. 145–160, 2009. View at Google Scholar · View at Scopus
  12. L. Rosenberg, K. S. Nanda, T. Zenlea et al., “Histologic markers of inflammation in patients with ulcerative colitis in clinical remission,” Clinical Gastroenterology and Hepatology, vol. 11, no. 8, pp. 991–996, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Bessissow, B. Lemmens, M. Ferrante et al., “Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing,” The American Journal of Gastroenterology, vol. 107, no. 11, pp. 1684–1692, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Schoepfer, C. Beglinger, A. Straumann, M. Trummler, P. Renzulli, and F. Seibold, “Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes,” Inflammatory Bowel Diseases, vol. 15, no. 12, pp. 1851–1858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Karoui, S. Laz, M. Serghini, N. Bibani, J. Boubaker, and A. Filali, “Correlation of C-reactive protein with clinical and endoscopic activity in patients with ulcerative colitis,” Digestive Diseases and Sciences, vol. 56, no. 6, pp. 1801–1805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Osada, T. Ohkusa, I. Okayasu et al., “Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis,” Journal of Gastroenterology and Hepatology, vol. 23, supplement 2, pp. S262–S267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. H. Lok, C. H. Ng, H. G. Hung, K. F. Li, K. K. Li, and M. L. Szeto, “Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients,” Journal of Digestive Diseases, vol. 9, no. 4, pp. 219–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. Solem, E. V. Loftus Jr., W. J. Tremaine, W. S. Harmsen, A. R. Zinsmeister, and W. J. Sandborn, “Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 11, no. 8, pp. 707–712, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Rutgeerts, W. J. Sandborn, B. G. Feagan et al., “Infliximab for induction and maintenance therapy for ulcerative colitis,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2462–2476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. W. J. Sandborn, G. Van Assche, W. Reinisch et al., “Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis,” Gastroenterology, vol. 142, no. 2, pp. 257–265.e3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. P. L. Travis, D. Schnell, P. Krzeski et al., “Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS),” Gut, vol. 61, no. 4, pp. 535–542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. T. de Lange, S. Larsen, and L. Aabakken, “Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis,” BMC Gastroenterology, vol. 4, article 9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Vermeire, G. Van Assche, and P. Rutgeerts, “The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases,” Nature Clinical Practice Gastroenterology & Hepatology, vol. 2, no. 12, pp. 580–586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. D. Rodgers and A. G. Cummins, “CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease,” Digestive Diseases and Sciences, vol. 52, no. 9, pp. 2063–2068, 2007. View at Google Scholar
  25. E. A. Fagan, R. F. Dyck, P. N. Maton et al., “Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis,” European Journal of Clinical Investigation, vol. 12, no. 4, pp. 351–359, 1982. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Henriksen, J. Jahnsen, I. Lygren et al., “C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study,” Gut, vol. 57, no. 11, pp. 1518–1523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. D. Lewis, S. Chuai, L. Nessel, G. R. Lichtenstein, F. N. Aberra, and J. H. Ellenberg, “Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis,” Inflammatory Bowel Diseases, vol. 14, no. 12, pp. 1660–1666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Turner, C. H. Seow, G. R. Greenberg, A. M. Griffiths, M. S. Silverberg, and A. H. Steinhart, “A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis,” Clinical Gastroenterology and Hepatology, vol. 7, no. 10, pp. 1081–1088, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. C. Truelove and W. C. Richards, “Biopsy studies in ulcerative colitis,” British Medical Journal, vol. 1, no. 4979, pp. 1315–1318, 1956. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Isgar, M. Harman, M. D. Kaye, and P. J. Whorwell, “Symptoms of irritable bowel syndrome in ulcerative colitis in remission,” Gut, vol. 24, no. 3, pp. 190–192, 1983. View at Publisher · View at Google Scholar · View at Scopus
  31. I. M. Minderhoud, B. Oldenburg, J. A. Wismeijer, G. P. V. B. Henegouwen, and A. J. P. M. Smout, “IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior,” Digestive Diseases and Sciences, vol. 49, no. 3, pp. 469–474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Fukuba, S. Ishihara, Y. Tada et al., “Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study,” Scandinavian Journal of Gastroenterology, vol. 49, no. 6, pp. 674–680, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-Y. Xiang, Q. Ouyang, G.-D. Li, and N.-P. Xiao, “Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis,” World Journal of Gastroenterology, vol. 14, no. 1, pp. 53–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. I. K. Önal, Y. Beyazit, B. Şener et al., “The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis,” Turkish Journal of Gastroenterology, vol. 23, no. 5, pp. 509–514, 2012. View at Publisher · View at Google Scholar · View at Scopus